208 related articles for article (PubMed ID: 29574346)
1. Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine.
Tang MHY; Ching CK; Poon S; Chan SSS; Ng WY; Lam M; Wong CK; Pao R; Lau A; Mak TWL
Forensic Sci Int; 2018 May; 286():113-120. PubMed ID: 29574346
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
Musshoff F; Hokamp EG; Bott U; Madea B
Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
[TBL] [Abstract][Full Text] [Related]
3. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
[TBL] [Abstract][Full Text] [Related]
5. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Krotulski AJ; Mohr ALA; Friscia M; Logan BK
J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
[TBL] [Abstract][Full Text] [Related]
6. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of rapid point-of-collection oral fluid drug-testing devices.
Walsh JM; Flegel R; Crouch DJ; Cangianelli L; Baudys J
J Anal Toxicol; 2003 Oct; 27(7):429-39. PubMed ID: 14606995
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of on-site oral fluid drug screening devices DrugWipe 5+ and Rapid STAT using oral fluid for confirmation analysis.
Pehrsson A; Blencowe T; Vimpari K; Langel K; Engblom C; Lillsunde P
J Anal Toxicol; 2011 May; 35(4):211-8. PubMed ID: 21513614
[TBL] [Abstract][Full Text] [Related]
9. Opioids in oral fluid of Spanish drivers.
Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Álvarez FJ
Drug Alcohol Depend; 2018 Jun; 187():35-39. PubMed ID: 29626744
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.
Strano-Rossi S; Castrignanò E; Anzillotti L; Serpelloni G; Mollica R; Tagliaro F; Pascali JP; di Stefano D; Sgalla R; Chiarotti M
Forensic Sci Int; 2012 Sep; 221(1-3):70-6. PubMed ID: 22554872
[TBL] [Abstract][Full Text] [Related]
11. Analytical evaluation of four on-site oral fluid drug testing devices.
Vanstechelman S; Isalberti C; Van der Linden T; Pil K; Legrand SA; Verstraete AG
J Anal Toxicol; 2012 Mar; 36(2):136-40. PubMed ID: 22337784
[TBL] [Abstract][Full Text] [Related]
12. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
Gjerde H; Langel K; Favretto D; Verstraete AG
Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of selected oral fluid point-of-collection drug-testing devices.
Crouch DJ; Walsh JM; Flegel R; Cangianelli L; Baudys J; Atkins R
J Anal Toxicol; 2005; 29(4):244-8. PubMed ID: 15975256
[TBL] [Abstract][Full Text] [Related]
14. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
[TBL] [Abstract][Full Text] [Related]
15. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
[TBL] [Abstract][Full Text] [Related]
17. Illicit Drugs in Oral Fluid: Evaluation of Two Collection Devices.
Cohier C; Mégarbane B; Roussel O
J Anal Toxicol; 2017 Jan; 41(1):71-76. PubMed ID: 27681339
[TBL] [Abstract][Full Text] [Related]
18. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.
Samyn N; van Haeren C
Int J Legal Med; 2000; 113(3):150-4. PubMed ID: 10876986
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
Cone EJ; Clarke J; Tsanaclis L
J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
[TBL] [Abstract][Full Text] [Related]
20. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
Logan BK; Mohr AL; Talpins SK
J Anal Toxicol; 2014 Sep; 38(7):444-50. PubMed ID: 24894458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
